Clinical Trial

Efficacy of a Dietary Supplement in Infants

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a double-blind, randomized, placebo-controlled nutritional study of healthy term infants. The primary objective of the trial is to demonstrate a favorable change in fecal microbiome composition in infants receiving a dietary supplement compared to infants receiving a placebo supplement.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12 -> 2027-06 2026-04-25
minor Completion pushed: 2027-07 -> 2027-12 2026-04-25
Trial Details
NCT Number NCT07341477
Lead Sponsor Société des Produits Nestlé (SPN)
Conditions Healthy Infants
Enrollment 172 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-24